Pennsylvania court: “Overall anticompetitive scheme” alleged in Suboxone litigation

A swathe of claims from direct purchasers, end consumers and state attorneys general accusing Indivior of monopolising the market for opioid addiction treatment Suboxone have survived the pharmaceutical company’s motion for summary judgment.

Unlock unlimited access to all Global Competition Review content